Onco Wiki / Enfermedad

Tumor de células germinales testiculares (TCG)

Vista determinista de la entidad fuente YAML. La autoridad clínica sigue con los ID de fuente citados y estado de firma del revisor.

IDDIS-TESTICULAR-GCT
TipoEnfermedad
Aliaces
Tumor de células germinales (TCG)Non-seminomatous germ cell tumor (NSGCT)SeminomaCáncer testicularTumor de células germinativas testicularesTCG mixto testicularГерміногенна пухлина яєчка
Situaciónreviewed 2026-05-04 | pending_clinical_signoff
EnfermedadesNinguna declarada
FuentesNinguna declarada

Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.

Fuente YAML

icd_o_3_morphology9061/3
icd_o_3_topography["C62.0", "C62.1", "C62.9"]
icd_10C62.9
who_classificationWHO Urinary and Male Genital Tumours 5th ed (2022): Germ cell tumours

Capacidades

Notas

Testicular GCT is the most common solid tumor in men aged 15-35 and one of the most curable cancers even at metastatic stage (BEP-based chemotherapy cures ~80-92% of metastatic good/intermediate-risk GCT; ~50% poor-risk). Early diagnosis via self-examination + ultrasound is critical. All staging workup requires serum AFP, beta-hCG, LDH at diagnosis and post-orchiectomy to determine marker trajectory. RPLND (retroperitoneal lymph node dissection) is used for: residual masses after chemotherapy (seminoma → PET-guided; NSGCT → surgery for >1cm residual), pathologic stage I NSGCT surveillance-alternative.

Utilizado por

Algoritmos

Indicación

Cuestionarios

Esquema terapéutico

Fuentes